Spear Matthew A.
Insider CIK 1766302 · PSTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-01 | 72,568 | — | $0 | 72,568 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-03-01 | 2022-03-01 | 50,000 | — | $0 | 111,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-12-06 | 2021-12-08 | 10,000 | — | $0 | 70,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-12-06 | 2021-12-08 | 10,000 | $1.32 | $13.2K | 61,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-09-09 | 2021-09-10 | 10,000 | — | $0 | 80,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-09-09 | 2021-09-10 | 10,000 | $1.32 | $13.2K | 51,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-08-20 | 2021-08-24 | 4,000 | — | $0 | 90,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-08-20 | 2021-08-24 | 4,000 | $1.32 | $5.3K | 45,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-08-20 | 2021-08-24 | 4,000 | $8.79 | $35.2K | 41,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-07-28 | 2021-07-30 | 20,000 | — | $0 | 94,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-07-28 | 2021-07-30 | 20,000 | $1.32 | $26.4K | 41,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-06-17 | 2021-06-21 | 5,000 | — | $0 | 114,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-06-17 | 2021-06-21 | 5,000 | $1.32 | $6.6K | 21,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-06-11 | 2021-06-14 | 4,000 | — | $0 | 119,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-06-11 | 2021-06-14 | 4,000 | $9.44 | $37.8K | 16,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-06-11 | 2021-06-14 | 4,000 | $1.32 | $5.3K | 20,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-04-23 | 2021-04-23 | 5,000 | — | $0 | 123,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-04-23 | 2021-04-23 | 5,000 | $1.32 | $6.6K | 16,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-04-21 | 2021-04-23 | 4,000 | — | $0 | 128,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-21 | 2021-04-23 | 4,000 | $8.44 | $33.8K | 11,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-04-21 | 2021-04-23 | 4,000 | $1.32 | $5.3K | 15,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 164,000 | — | $0 | 164,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-19 | 7,564 | — | $0 | 132,861 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-01-15 | 2021-01-19 | 7,564 | $1.32 | $10.0K | 11,485 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-01-08 | 2021-01-11 | 3,921 | — | $0 | 140,425 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-01-08 | 2021-01-11 | 3,921 | $1.32 | $5.2K | 3,921 | SEC↗ |